미국의 말초혈관 기기 및 부속품 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별 및 부문별 예측(2026-2033년)

U.S. Peripheral Vascular Devices And Accessories Market Summary

The U.S. peripheral vascular devices and accessories market size was estimated at USD 4.1 billion in 2025 and is projected to reach USD 6.2 billion by 2033, growing at a CAGR of 5.1% from 2026 to 2033. The industry is driven by the rising prevalence of peripheral arterial disease (PAD), fueled by aging and lifestyle factors.

Technological advancements, such as minimally invasive procedures and innovative devices, are enhancing treatment effectiveness. In addition, the growing geriatric population, more prone to vascular conditions, is increasing the demand for vascular interventions and devices.

The market is undergoing a significant transformation driven by rising clinical demand, technological advancements, and evolving care models. The shift toward minimally invasive procedures are also driving the market growth.

U.S. Peripheral Vascular Devices And Accessories Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. peripheral vascular devices and accessories market report based on product, application, and end use:

• Product Outlook (Revenue, USD Million, Unit Volume, In Thousand Units, 2021 - 2033)
• Peripheral Stents
  • Iliac Artery Stents
  • Femoral Artery Stents
  • Carotid Artery Stents
  • Renal Artery Stents
  • Others
• PTA Balloons
• Catheters
  • Angiography Catheters
  • Guiding Catheters
  • IVUS/OCT Catheters
• Endovascular Aneurysm Repair Stent Grafts
  • Thoracic Endovascular Aneurysm Stent Grafts
  • Abdominal Endovascular Aneurysm Stent Grafts
• Plaque Modification Devices
  • Atherectomy Devices
  • Thrombectomy Devices
• Peripheral Accessories
  • Guidewires
  • Workhorse Guidewires
  • Specialty Guidewires
  • Extra Support Guidewires
  • Frontline Finesse Guidewires
  • Peripheral Vascular Closure Devices
  • Balloon Inflation Devices
  • Introducer Sheaths
• Inferior Vena Cava Filters
  • Permanent Filters
  • Retrievable Filters
• Hemodynamic Flow Alteration Devices
  • Chronic Total Occlusion Devices
  • Embolic Protection Devices
• Application Outlook (Revenue, USD Million, Unit Volume, In Thousand Units, 2021 - 2033)
• Peripheral Arterial Disease (PAD)
• Aneurysms
• Venous Diseases
• Others
• End Use Outlook (Revenue, USD Million, Unit Volume, In Thousand Units, 2021 - 2033)
• Hospitals
• Ambulatory Surgical Centers
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. End-use
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Volume price analysis (Model 2)
  • 1.7.3. Three pillars of market estimation
  • 1.7.4. Market modeling & forecasting
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End Use outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Peripheral Vascular Devices and Accessories Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising prevalence & increasing diagnosis of peripheral artery disease (PAD)
    • 3.2.1.2. Growing burden of diabetes and diabetes related PAD
    • 3.2.1.3. Increasing adoption of minimally invasive endovascular procedures
    • 3.2.1.4. Technologically advanced product launches in peripheral vascular devices
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High treatment costs
    • 3.2.2.2. Regulatory and approval challenges
  • 3.2.3. Market restraint analysis
    • 3.2.3.1. High treatment costs
    • 3.2.3.2. Product recalls and safety concerns
  • 3.2.4. Market opportunity analysis
    • 3.2.4.1. Growing office based laboratories for peripheral vascular interventions
    • 3.2.4.2. AI based predictive modeling to optimize endovascular intervention outcomes in PAD
    • 3.2.4.3. Rising revolution in peripheral CTO intervention devices
  • 3.2.5. Market challenge analysis
    • 3.2.5.1. Declining medicare reimbursements
    • 3.2.5.2. Shortage of skilled specialists for complex peripheral vascular interventions
• 3.3. U.S. Peripheral Vascular Access Devices and Accessories Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
• 3.4. Regulatory Framework

Chapter 4. U.S. Peripheral Vascular Devices and Accessories Market Segment Analysis, By Product (Revenue in USD Million; Unit Volume, In Thousand Units; 2021 - 2033)

• 4.1. Definition and Scope
• 4.2. Product Market Share Analysis, 2025 & 2033
• 4.3. Segment Dashboard
• 4.4. U.S. Peripheral Vascular Devices and Accessories Market, by Product, 2021 to 2033 (USD Million)
• 4.5. Peripheral Stents
  • 4.5.1. Peripheral stents market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5.2. Peripheral stents market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
  • 4.5.3. Iliac artery stents
    • 4.5.3.1. Iliac artery stents market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.5.3.2. Iliac artery stents market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
  • 4.5.4. Femoral artery stents
    • 4.5.4.1. Femoral artery stents market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.5.4.2. Femoral artery stents market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
  • 4.5.5. Carotid artery stents
    • 4.5.5.1. Carotid artery stents market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.5.5.2. Carotid artery stents market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
  • 4.5.6. Renal artery stents
    • 4.5.6.1. Renal artery stents market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.5.6.2. Renal artery stents market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
  • 4.5.7. Others
    • 4.5.7.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.5.7.2. Others market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
• 4.6. PTA Balloons
  • 4.6.1. PTA balloons market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.2. PTA balloons market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
• 4.7. Catheters
  • 4.7.1. Catheters market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.7.2. Catheters market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
  • 4.7.3. Angiography catheters
    • 4.7.3.1. Angiography catheters market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.7.3.2. Angiography catheters market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
  • 4.7.4. Guiding catheters
    • 4.7.4.1. Guiding catheters market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.7.4.2. Guiding catheters market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
  • 4.7.5. IVUS/OCT Catheters
    • 4.7.5.1. IVUS/OCT catheters market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.7.5.2. IVUS/OCT catheters market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
• 4.8. Endovascular Aneurysm Repair Stent Grafts
  • 4.8.1. Endovascular aneurysm repair stent grafts market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.8.2. Endovascular aneurysm repair stent grafts market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
  • 4.8.3. Thoracic endovascular aneurysm stent grafts
    • 4.8.3.1. Thoracic endovascular aneurysm stent grafts market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.8.3.2. Thoracic endovascular aneurysm stent grafts market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
  • 4.8.4. Abdominal endovascular aneurysm stent grafts
    • 4.8.4.1. Abdominal endovascular aneurysm stent grafts market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.8.4.2. Abdominal endovascular aneurysm stent grafts market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
• 4.9. Plaque Modification Devices
  • 4.9.1. Plaque modification devices market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.9.2. Plaque modification devices market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
  • 4.9.3. Atherectomy devices
    • 4.9.3.1. Atherectomy devices market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.9.3.2. Atherectomy devices market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
  • 4.9.4. Thrombectomy devices
    • 4.9.4.1. Thrombectomy devices market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.9.4.2. Thrombectomy devices market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
• 4.10. Peripheral Accessories
  • 4.10.1. Peripheral accessories market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.10.2. Peripheral accessories market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
  • 4.10.3. Guidewires
    • 4.10.3.1. Guidewires market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.10.3.2. Guidewires market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
    • 4.10.3.3. Workhorse guidewires
      • 4.10.3.3.1. Workhorse guidewires market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.10.3.3.2. Workhorse guidewires market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
    • 4.10.3.4. Specialty guidewires
      • 4.10.3.4.1. Specialty guidewires market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.10.3.4.2. Specialty guidewires market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
    • 4.10.3.5. Extra support guidewires
      • 4.10.3.5.1. Extra support guidewires market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.10.3.5.2. Extra support guidewires market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
    • 4.10.3.6. Frontline finesse guidewires
      • 4.10.3.6.1. Frontline finesse guidewires market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.10.3.6.2. Frontline finesse guidewires market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
  • 4.10.4. Peripheral vascular closure devices
    • 4.10.4.1. Peripheral vascular closure devices market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.10.4.2. Peripheral vascular closure devices market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
  • 4.10.5. Balloon inflation devices
    • 4.10.5.1. Balloon inflation devices market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.10.5.2. Balloon inflation devices market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
  • 4.10.6. Introducer sheaths
    • 4.10.6.1. Introducer sheaths market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.10.6.2. Introducer sheaths market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
• 4.11. Inferior vena cava filters
  • 4.11.1. Inferior vena cava filters market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.11.2. Inferior vena cava filters market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
  • 4.11.3. Permanent filters
    • 4.11.3.1. Permanent filters market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.11.3.2. Permanent filters market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
  • 4.11.4. Retrievable filters
    • 4.11.4.1. Retrievable filters market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.11.4.2. Retrievable filters market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
• 4.12. Hemodynamic flow alteration devices
  • 4.12.1. Hemodynamic flow alteration devices market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.12.2. Hemodynamic flow alteration devices market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
  • 4.12.3. Chronic total occlusion devices
    • 4.12.3.1. Chronic total occlusion devices market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.12.3.2. Chronic total occlusion devices market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)
  • 4.12.4. Embolic protection devices
    • 4.12.4.1. Embolic protection devices market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.12.4.2. Embolic protection devices market estimates and forecasts, 2021 to 2033 (Unit Volume, In Thousand Units)

Chapter 5. U.S. Peripheral Vascular Devices and Accessories Market: Application Estimates & Trend Analysis

• 5.1. Definition and Scope
• 5.2. Application Market Share Analysis, 2025 & 2033
• 5.3. Segment Dashboard
• 5.4. U.S. Peripheral Vascular Devices and Accessories Market, by Application, 2021 to 2033 (USD Million)
• 5.5. Peripheral Arterial Disease (PAD)
  • 5.5.1. Peripheral Arterial Disease (PAD) market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.6. Aneurysms
  • 5.6.1. Aneurysms market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.7. Venous Diseases
  • 5.7.1. Venous diseases market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.8. Others
  • 5.8.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. U.S. Peripheral Vascular Devices and Accessories Market: End Use Estimates & Trend Analysis

• 6.1. Definition and Scope
• 6.2. Application Market Share Analysis, 2025 & 2033
• 6.3. Segment Dashboard
• 6.4. U.S. Peripheral Vascular Devices and Accessories Market, by End Use, 2021 to 2033 (USD Million)
• 6.5. Hospitals
  • 6.5.1. Hospitals market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.6. Ambulatory Surgical Centers
  • 6.6.1. Ambulatory surgical centers market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.7. Others
  • 6.7.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company/Competition Categorization (Key innovators, market leaders, emerging players)
• 7.2. Company Market Share Analysis, 2025
• 7.3. Competitive Landscape & Strategic Opportunity Analysis for NIPRO & Terumo Corporation in the U.S. Vascular Devices Market
  • 7.3.1. Competitive positioning matrix
  • 7.3.2. Distribution strength comparison
  • 7.3.3. Technology leadership analysis
  • 7.3.4. Investment & strategic insights
  • 7.3.5. Competitive threat assessment for NIPRO & Terumo Corporation
  • 7.3.6. Competitive white space identification
  • 7.3.7. Abbott
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Terumo Medical Corporation
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Nipro
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Medtronic
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. Boston Scientific Corporation
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Product benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. Cordis
    • 7.3.12.1. Company overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Product benchmarking
    • 7.3.12.4. Strategic initiatives
  • 7.3.13. Koninklijke Philips N.V.,
    • 7.3.13.1. Company overview
    • 7.3.13.2. Financial performance
    • 7.3.13.3. Product benchmarking
    • 7.3.13.4. Strategic initiatives
  • 7.3.14. AngioDynamics.
    • 7.3.14.1. Company overview
    • 7.3.14.2. Financial performance
    • 7.3.14.3. Product benchmarking
    • 7.3.14.4. Strategic initiatives
  • 7.3.15. ASAHI INTECC CO., LTD.
    • 7.3.15.1. Company overview
    • 7.3.15.2. Financial performance
    • 7.3.15.3. Product benchmarking
    • 7.3.15.4. Strategic initiatives
  • 7.3.16. BD
    • 7.3.16.1. Company overview
    • 7.3.16.2. Financial performance
    • 7.3.16.3. Product benchmarking
    • 7.3.16.4. Strategic initiatives
  • 7.3.17. Teleflex Incorporated. (Biotronik)
    • 7.3.17.1. Company overview
    • 7.3.17.2. Financial performance
    • 7.3.17.3. Product benchmarking
    • 7.3.17.4. Strategic initiatives
  • 7.3.18. Edward Lifesciences Corporation
    • 7.3.18.1. Company overview
    • 7.3.18.2. Financial performance
    • 7.3.18.3. Product benchmarking
    • 7.3.18.4. Strategic initiatives
  • 7.3.19. B. Braun SE
    • 7.3.19.1. Company overview
    • 7.3.19.2. Financial performance
    • 7.3.19.3. Product benchmarking
    • 7.3.19.4. Strategic initiatives
  • 7.3.20. W. L. Gore & Associates, Inc.
    • 7.3.20.1. Company overview
    • 7.3.20.2. Financial performance
    • 7.3.20.3. Product benchmarking
    • 7.3.20.4. Strategic initiatives
  • 7.3.21. Merit Medical Systems, Inc.
    • 7.3.21.1. Company overview
    • 7.3.21.2. Financial performance
    • 7.3.21.3. Product benchmarking
    • 7.3.21.4. Strategic initiatives
  • 7.3.22. Cook
    • 7.3.22.1. Company overview
    • 7.3.22.2. Financial performance
    • 7.3.22.3. Product benchmarking
    • 7.3.22.4. Strategic initiatives